首页 > 市场调查报告书 > 医疗设备

体外诊断呼吸器

呼吸系统疾病检测市场规模、份额和成长分析（按检测类型、应用和地区划分）—2026-2033年产业预测

市场调查报告书

商品编码

1904414

呼吸系统疾病检测市场规模、份额和成长分析（按检测类型、应用和地区划分）—2026-2033年产业预测

Respiratory Disease Testing Market Size, Share, and Growth Analysis, By Test Type (Mechanical Tests, Imaging Tests), By Application (Lung Cancer, Asthma), By Region - Industry Forecast 2026-2033

出版日期: 2025年12月24日 | 出版商:

SkyQuest | 英文 157 Pages | 商品交期: 3-5个工作天内

价格

简介目录

预计到 2024 年，呼吸系统疾病检测市场规模将达到 84.6 亿美元，到 2025 年将达到 91.8 亿美元，到 2033 年将达到 176.4 亿美元，在预测期（2026-2033 年）内复合年增长率为 8.5%。

全球呼吸系统疾病检测市场正经历强劲成长，这主要受空气污染和人口老化等因素导致气喘、慢性阻塞性肺病（COPD）和肺癌等疾病发病率上升的推动。分子诊断、免疫检测和影像技术的进步使得早期检测和个人化治疗方法方案成为可能，从而推动了对精准高效诊断方法的需求激增。尤其是在新冠疫情期间，呼吸系统疾病检测的重要性日益凸显，人们对包括PCR检测和抗原检测在内的各种检测方法的依赖性也随之增强。然而，高昂的检测成本、发展中地区基础设施有限以及监管障碍等挑战仍需克服，才能最大限度地发挥市场潜力。开展教育和提高公众意识的活动对于促进检测方案的广泛应用和改善患者就医途径至关重要。

呼吸系统疾病检测市场驱动因素

气喘、慢性阻塞性肺病（COPD）和肺癌等呼吸系统疾病的发生率和盛行率不断上升，显着推动了呼吸系统疾病检测市场的发展。环境污染、吸烟和人口老化等因素加剧了这些疾病带来的全球性挑战，凸显了可靠有效的检测解决方案的必要性。随着对精准诊断需求的不断增长，医疗服务提供者和患者都在寻求先进的检测方法来应对呼吸系统疾病带来的负担，这既展现了市场成长潜力，也凸显了製定创新医疗策略以解决这些健康问题的紧迫性。

呼吸系统疾病检测市场的限制因素

由于法规结构复杂且新检测技术需要严格的核准程序，呼吸系统疾病检测市场面临许多挑战。这些严格的法规可能对市场参与企业构成重大障碍，因为获得必要的核准通常需要高成本大量时间和成本。这些延误会阻碍创新产品的及时上市，最终阻碍呼吸系统疾病诊断技术的进步，并限制市场成长潜力。总而言之，监管合规的复杂性可能成为企业推出新型和改进型呼吸系统疾病检测解决方案的一大阻碍因素。

呼吸系统疾病检测市场趋势

呼吸系统疾病检测市场正呈现显着的趋势，即采用即时检测解决方案。这一趋势的驱动力在于对快速诊断的需求日益增长，尤其是在重症监护室和资源匮乏地区，患者需要能够在床边直接进行治疗决策。对及时准确结果的需求不断增长，促使医疗机构采用先进的照护现场设备和平台，从而改善患者预后并简化临床工作流程。随着医疗体系的不断发展，对快速且有效率检测方法的关注必将改变呼吸系统疾病诊断领域，并成为该市场的关键成长点。

北美洲
- 美国
- 加拿大
欧洲
- 德国
- 西班牙
- 法国
- 英国
- 义大利
- 其他欧洲地区
亚太地区
- 中国
- 印度
- 日本
- 韩国
- 亚太其他地区
拉丁美洲
- 巴西
- 其他拉丁美洲地区
中东和非洲
- 海湾合作委员会国家
- 南非
- 其他中东和非洲地区

竞争资讯

前五大公司对比
主要企业的市场定位（2025 年）
主要市场参与者所采取的策略
近期市场趋势
公司市占率分析（2025 年）
主要企业公司简介
- 公司详情
- 产品系列分析
- 依业务板块进行公司股票分析
- 2021-2023年营收年比比较

主要企业简介

Beckton Dickinson and Company
Koninklijke Philips NV
ResMed Inc.
Medtronic
MG Diagnostic Corporation
Abbott
ThermoFisher Scientific
Biomerieux
QIAGEN
Seimens Healthineers AG
F. Hoffmann-La Roche Ltd
SDI Diagnostics
BD
Niterra Co., Ltd.
QuantuMDx Group Ltd.
COSMED srl
Bird Healthcare
visby medical
Seegene Inc
Bio-Rad Laboratories Inc

结论与建议

简介目录

Product Code: SQMIG35A2825

Respiratory Disease Testing Market size was valued at USD 8.46 Billion in 2024 and is poised to grow from USD 9.18 Billion in 2025 to USD 17.64 Billion by 2033, growing at a CAGR of 8.5% during the forecast period (2026-2033).

The global respiratory disease testing market is witnessing robust growth, fueled by rising incidences of conditions like asthma, COPD, and lung cancer, driven by factors such as pollution and an aging population. The demand for precise and efficient diagnostic methods has surged, supported by technological advancements in molecular diagnostics, immunoassays, and imaging techniques, enabling early detection and tailored treatment options. Notably, the COVID-19 pandemic has elevated the importance of respiratory testing, prompting an increased reliance on various testing modalities, including PCR and antigen tests. However, challenges such as high testing costs, limited infrastructure in developing regions, and regulatory hurdles must be addressed to maximize market potential. Education and awareness initiatives are crucial to encourage widespread adoption and improve patient access to testing solutions.

Top-down and bottom-up approaches were used to estimate and validate the size of the Respiratory Disease Testing market and to estimate the size of various other dependent submarkets. The research methodology used to estimate the market size includes the following details: The key players in the market were identified through secondary research, and their market shares in the respective regions were determined through primary and secondary research. This entire procedure includes the study of the annual and financial reports of the top market players and extensive interviews for key insights from industry leaders such as CEOs, VPs, directors, and marketing executives. All percentage shares split, and breakdowns were determined using secondary sources and verified through Primary sources. All possible parameters that affect the markets covered in this research study have been accounted for, viewed in extensive detail, verified through primary research, and analyzed to get the final quantitative and qualitative data.

Respiratory Disease Testing Market Segments Analysis

Global Respiratory Disease Testing Market is segmented by test type, application, end-use and region. Based on test type, the market is segmented into mechanical tests, imaging tests and in-vitro diagnostic tests. Based on application, the market is segmented into chronic obstructive pulmonary disease, lung cancer, asthma, tuberculosis and other. Based on end-use, the market is segmented into hospital, physicians clinic and clinical laboratories. Based on region, the market is segmented into North America, Europe, Asia Pacific, Latin America and Middle East & Africa.

Driver of the Respiratory Disease Testing Market

The increasing occurrence and frequency of respiratory diseases, including asthma, chronic obstructive pulmonary disease (COPD), and lung cancer, significantly propel the respiratory disease testing market. Contributing elements such as environmental pollution, tobacco use, and an aging demographic intensify the global challenge posed by these conditions, underscoring the necessity for reliable and effective testing solutions. As the demand for accurate diagnostics rises, healthcare providers and patients alike seek advanced testing methods to address the burden of respiratory illnesses, highlighting the market's growth potential and the urgent need for innovative healthcare strategies to combat these health issues.

Restraints in the Respiratory Disease Testing Market

The Respiratory Disease Testing market faces significant challenges due to the intricate regulatory frameworks and rigorous approval procedures required for new testing technologies. These stringent regulations can create substantial obstacles for market participants, as securing necessary approvals often involves lengthy and costly processes. Such delays can hinder the timely launch of innovative products, ultimately stifling advancements in respiratory disease diagnostics and limiting the growth potential of the market. Overall, the complexities surrounding regulatory compliance can serve as a considerable restraint for companies aiming to introduce new and improved testing solutions for respiratory diseases.

Market Trends of the Respiratory Disease Testing Market

The Respiratory Disease Testing market is witnessing a significant trend towards the proliferation of point-of-care testing solutions. This shift is fueled by an increasing need for rapid diagnostics that enable immediate treatment decisions directly at the bedside, particularly in critical care settings and areas with limited resources. The demand for timely and precise results is prompting healthcare providers to adopt advanced point-of-care devices and platforms, thereby enhancing patient outcomes and streamlining clinical workflows. As healthcare systems evolve, the focus on quick and efficient testing methods is set to transform the landscape of respiratory diagnostics, making it a key area of growth within the market.

Introduction

Objectives of the Study
Scope of the Report
Definitions

Research Methodology

Information Procurement
Secondary & Primary Data Methods
Market Size Estimation
Market Assumptions & Limitations

Executive Summary

Global Market Outlook
Supply & Demand Trend Analysis
Segmental Opportunity Analysis

Market Dynamics & Outlook

Market Overview
Market Size
Market Dynamics
- Drivers & Opportunities
- Restraints & Challenges
Porters Analysis
- Competitive rivalry
- Threat of substitute
- Bargaining power of buyers
- Threat of new entrants
- Bargaining power of suppliers

Key Market Insights

Key Success Factors
Degree of Competition
Top Investment Pockets
Market Ecosystem
Market Attractiveness Index, 2025
PESTEL Analysis
Macro-Economic Indicators
Value Chain Analysis
Pricing Analysis
Technological Advancement
Regulatory Landscape
Case Studies

Global Respiratory Disease Testing Market Size by Test Type & CAGR (2026-2033)

Market Overview
Mechanical Tests
- Spirometry
- Peak-Flow Test
- Pulmonary Function Test
- Blood Gas Test
- Others
Imaging Tests
- X-Ray
- Ct-Scan
- Ultrasonography
- Mri
In-Vitro Diagnostic Tests
- Point-Of-Care Test
- Molecular Diagnostic Test

Global Respiratory Disease Testing Market Size by Application & CAGR (2026-2033)

Market Overview
Chronic Obstructive Pulmonary Disease
Lung Cancer
Asthma
Tuberculosis
Other

Global Respiratory Disease Testing Market Size by End-Use & CAGR (2026-2033)

Market Overview
Hospital
Physicians Clinic
Clinical Laboratories

Global Respiratory Disease Testing Market Size & CAGR (2026-2033)

North America (Test Type, Application, End-Use)
- USA
- Canada
Europe (Test Type, Application, End-Use)
- Germany
- Spain
- France
- UK
- Italy
- Rest of Europe
Asia Pacific (Test Type, Application, End-Use)
- China
- India
- Japan
- South Korea
- Rest of Asia-Pacific
Latin America (Test Type, Application, End-Use)
- Brazil
- Rest of Latin America
Middle East & Africa (Test Type, Application, End-Use)
- GCC Countries
- South Africa
- Rest of Middle East & Africa

Competitive Intelligence

Top 5 Player Comparison
Market Positioning of Key Players, 2025
Strategies Adopted by Key Market Players
Recent Developments in the Market
Company Market Share Analysis, 2025
Company Profiles of All Key Players
- Company Details
- Product Portfolio Analysis
- Company's Segmental Share Analysis
- Revenue Y-O-Y Comparison (2021-2023)

Key Company Profiles

Beckton Dickinson and Company
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Koninklijke Philips N.V.
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
ResMed Inc.
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Medtronic
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
MG Diagnostic Corporation
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Abbott
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
ThermoFisher Scientific
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Biomerieux
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
QIAGEN
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Seimens Healthineers AG
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
F. Hoffmann-La Roche Ltd
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
SDI Diagnostics
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
BD
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Niterra Co., Ltd.
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
QuantuMDx Group Ltd.
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
COSMED srl
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Bird Healthcare
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
visby medical
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Seegene Inc
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Bio-Rad Laboratories Inc
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments